(Q39511405)

12 September 2017

Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling (English)

1 reference

12 September 2017

0 references

Pasqualino De Antonellis

4

object named as

Pasqualino De Antonellis

0 references

author name string

Flora Cimmino

1

1 reference

12 September 2017

Maria Nunzia Scoppettuolo

2

1 reference

12 September 2017

Marianeve Carotenuto

3

1 reference

12 September 2017

Pasqualino De Antonellis

4

1 reference

12 September 2017

Valeria Di Dato

5

1 reference

12 September 2017

Gennaro De Vita

6

1 reference

12 September 2017

Massimo Zollo

7

1 reference

12 September 2017

7 July 2011

1 reference

Journal of Neuro-Oncology

12 September 2017

1 reference

12 September 2017

106

1 reference

12 September 2017

1

1 reference

12 September 2017

59-70

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-011-0645-y

12 September 2017

0 references

cites work

Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Correlative analyses of notch signaling with resveratrol-induced differentiation and apoptosis of human medulloblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

The origins of medulloblastoma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Signaling pathways in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Chromosome 1q gain is not associated with a poor outcome in childhood medulloblastoma: requirements for the validation of potential prognostic biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Medulloblastoma comprises four distinct molecular variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Molecular modes of action of cantharidin in tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Molecular biology of cantharidin in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Cytotoxicity of cantharidin analogues targeting protein phosphatase 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Cantharidin-induced cytotoxicity and cyclooxygenase 2 expression in human bladder carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

The effect of cantharidins on leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Cantharidin induces apoptosis of human multiple myeloma cells via inhibition of the JAK/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Inhibitory effects of norcantharidin against human lung cancer cell growth and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Norcantharidin induces HT-29 colon cancer cell apoptosis through the alphavbeta6-extracellular signal-related kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Cantharidin-induced mitotic arrest is associated with the formation of aberrant mitotic spindles and lagging chromosomes resulting, in part, from the suppression of PP2Aalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

PP2A:B56ϵ is required for Wnt/β-catenin signaling during embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Wnt signaling controls the phosphorylation status of beta-catenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

In vitro assessment of renal toxicity and inflammatory events of two protein phosphatase inhibitors cantharidin and nor-cantharidin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Mining the Wnt pathway for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Medulloblastoma: a disease with disorganized developmental signaling cascades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Protein phosphatase 2A (PP2A) holoenzymes regulate death-associated protein kinase (DAPK) in ceramide-induced anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Anticancer activity and mechanisms of norcantharidin-Nd3II on hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Evaluation of anti-Wnt/β-catenin signaling agents by pGL4-TOP transfected stable cells with a luciferase reporter system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Survivin is a negative prognostic marker in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Signaling cross-talk between TGF-beta/BMP and other pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

An investigation on liver-targeting microemulsions of norcantharidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Wnt-Frizzled signalling and the many paths to neural development and adult brain homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Regulation of cerebral cortical size by control of cell cycle exit in neural precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

Heterocyclic substituted cantharidin and norcantharidin analogues—synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0645-Y

E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation

21 January 2018

1 reference

12 December 2020

Evidence of the cross talk between Wnt and Notch signaling pathways in non-small-cell lung cancer (NSCLC): Notch3-siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines

1 reference

12 December 2020

Medulloblastoma in association with the Coffin-Siris syndrome

1 reference

12 December 2020

Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action

1 reference

12 December 2020

10.1007/S11060-011-0645-Y

Identifiers

DOI

1 reference

12 September 2017

1 reference